AMGN compared with IPSC: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

IPSCCentury Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

478.34· pre 481.35· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

IPSCCentury Therapeutics, Inc.

1.67· pre 1.67· delayed

Pre-marketNov 5 '26delayed

Mkt cap$275.2MRevenue$109MQ1 FY25Revenue$7MFY24

Compare

Pre-marketNov 5 '26delayed

AMGNAmgen Inc

IPSCCentury Therapeutics, Inc.

478.34pre 481.35delayed

Price

1.67pre 1.67delayed

$258.8B

Mkt cap

$275.2M

Q3 FY26$10.4B

Revenue

$109MQ1 FY25

FY25$36.8B

Revenue

$7MFY24

AMGN478.34vsIPSC1.67Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IPSC: latest quarter not drawable.Method ›

Price

rebased to 0%

AMGN, solidIPSC, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only IPSC 7

BMYBristol-Myers Squibbcustomer

—FUJIFILM Cellular Dynamicsunlistedsupplier

—Catalent Dusseldorf GmbHunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Fcdi

unlistedsupplier

3 more · IPSC chain ›